Sessioni Comunicazioni Orali


Inflammation pharmacology and immunopharmacology - Session I

Martedì 27 Ottobre 2015 / 15.00-16.45
524Cross-talk between inflammation and aberrant mechano-transduction in degenerative primary myopathies: validation of druggable targets via animal models and pharmacological studies
Mantuano P., Cozzoli A., Capogrosso RF., Massari AM., De Benedictis L., Montagnani M., Camerino GM., Giustino A., Nagaraju K., De Luca A.
98Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory pain
Impellizzeri D., Di Paola R., Cordaro M., Casili G., Esposito E., Cuzzocrea S.
627Pharmacological inhibition of IκB kinase reduces the multiple organ dysfunction associated with hemorrhagic shock in the rat
Sordi S., Chiazza F., Johnson FL., Patel NSA., Brohi K., Collino M., Thiemermann C.
519Inflammation and insulin-resistance affect dendritic cell function
Parenti A., Paccosi S., Pala L., Silvano A., Barbaro V., Romagnoli P., Rotella CM.
515Molecular pathways involved in NO formation in myenteric neurons after in vivo ischemia/reperfusion injury in the rat small intestine
Giaroni C., Filpa V., Carpanese E., Pirrone C., Rainero A., Conti A., Moro E., Moriondo A., Negrini D., Crema F., Frigo G., Porta G.
511Cyanidin-3-O-glucoside modulates intestinal inflammatory response induced by TNF-α: an approach based on in vitro epithelial and epithelial-endothelial co-culture models
Speciale A., Ferrari D., Fratantonio D., Busà R., Saija A., Cimino F.
292Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels
Tortora C., Manzo I., Bellini G., Nobili B., Maione S., Rossi F.